Wikipedia -WSS

Wikipedia

author：focus 2025-09-27 23:52:16 - browse：3

Eli Lilly headquarters — Kristoffer Tripplaar/AP

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： JPM pitch from hospitals? Revenue streams outside of patient care

WSS

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

‘The Bear’ and hospitality in hospitals

Ohioans vote in high

A preacher's new calling: Diversifying neuroscience research

In venture capital firm's success, lessons for turning crisis into profit

CDC launches VaccineFinder tool to locate Covid

leisure time

Wikipedia

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

Sage's campaign to raise awareness of postpartum depression hits a nerve

Novavax promises a turnaround & Lilly roils the obesity market

Male doctors called my cancer incurable. A female doctor showed it wasn't

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Choosing scientific sides in the fight against Alzheimer's

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FTX founder Sam Bankman

Medicare details structure of new drug price negotiation program

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

leisure time

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Sage's campaign to raise awareness of postpartum depression hits a nerve

Ohioans vote in high

Ohioans vote in high

Wegovy cuts risk of cardiovascular events by 20%, study finds

hotspot

hotspot

focus

focus